Sequential design with boundaries approach in pediatric intervention research reduces sample size

Journal of Clinical Epidemiology

Volumn 63, Issue 1, 2010, Pages 19-27

  van der Lee, Johanna H ^a   Wesseling, Judit ^a,b   Tanck, Michael W ^c   Offringa, Martin ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b RED CROSS HOSPITAL   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Child; Epidemiologic research design; Ethics; Rare diseases; Sample size; Systematic review

Indexed keywords

ANALYTIC METHOD; CALCULATION; EFFECT SIZE; HUMAN; METHODOLOGY; MORTALITY; OUTCOME ASSESSMENT; PEDIATRICS; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SAMPLE SIZE; SEQUENTIAL ANALYSIS; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CONTROLLED CLINICAL TRIALS AS TOPIC; ETHICS, MEDICAL; HUMANS; INFANT; INFANT, NEWBORN; PEDIATRICS; RARE DISEASES; RESEARCH DESIGN; SAMPLE SIZE;

EID: 70649097002     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2009.07.005     Document Type: Review

References (54)

1. Caldwell P.H., Murphy S.B., Butow P.N., and Craig J.C. Clinical trials in children. Lancet 364 (2004) 803-811
2. Doyle L.W., Davis P.G., Morley C.J., McPhee A., and Carlin J.B. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial. Pediatrics 117 (2006) 75-83
3. Doyle L.W., Davis P.G., Morley C.J., McPhee A., and Carlin J.B. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone. Pediatrics 119 (2007) 716-721
4. Bloom B.T., and Clark R.H. Comparison of Infasurf (calfactant) and Survanta (beractant) in the prevention and treatment of respiratory distress syndrome. Pediatrics 116 (2005) 392-399
5. Murphy T.D., Anbar R.D., Lester L.A., Nasr S.Z., Nickerson B., VanDevanter D.R., et al. Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease. Pediatr Pulmonol 38 (2004) 314-320
6. Peto R., and Baigent C. Trials: the next 50 years. Large scale randomised evidence of moderate benefits. BMJ 317 (1998) 1170-1171
7. Roberts D., and Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3 (2006) CD004454
8. van der Lee J., Wesseling J., Tanck M., and Offringa M. Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases. J Clin Epidemiol 61 (2008) 324-330
9. Todd S. A 25-year review of sequential methodology in clinical studies. Stat Med 26 (2007) 237-252
10. Whitehead J. The design and analysis of sequential clinical trials (1997), John Wiley and Sons, Chichester
11. Wald A. Sequential analysis (1947), John Wiley and Sons, New York
12. Armitage P. Sequential medical trials (1975), Blackwell Scientific Publications, Oxford
13. Sebille V., and Bellissant E. Comparison of four sequential methods allowing for early stopping of comparative clinical trials. Clin Sci 98 (2000) 569-578
14. Altman D.G., Schulz K.F., Moher D., Egger M., Davidoff F., Elbourne D., et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134 (2001) 663-694
15. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 (2001) 1191-1194
16. Haastert B., and Giani G. On the sequential design of the Deutsche Nikotinamid Interventionsstudie-DENIS. Diab Metab 19 (1993) 100-104
17. Pohlandt F., Saule H., Schroder H., Leonhardt A., Hornchen H., Wolff C., et al. Decreased incidence of extra-alveolar air leakage or death prior to air leakage in high versus low rate positive pressure ventilation: results of a randomised seven-centre trial in preterm infants. Eur J Pediatr 151 (1992) 904-909
18. Carlo W.A., Siner B., Chatburn R.L., Robertson S., and Martin R.J. Early randomized intervention with high-frequency jet ventilation in respiratory distress syndrome. J Pediatr 117 (1990) 765-770
19. Thompson E.I. Application of restricted sequential design in a clinical protocol. Cancer Treat Rep 64 (1980) 399-403
20. Zuniga A., Burdach R., and Rubio S. Dimethyl sulfoxide therapy in bronchiolitis. Ann NY Acad Sci 243 (1975) 460-467
21. Gortner L., Bernsau U., Hellwege H.H., Hieronimi G., Jorch G., and Reiter H.L. Does prophylactic use of bovine surfactant change drug utilization in very premature infants during neonatal period?. Dev Pharmacol Ther 16 (1991) 1-6
22. Kao L.C., Warburton D., Cheng M.H., Cedeno C., Platzker A.C., and Keens T.G. Effect of oral diuretics on pulmonary mechanics in infants with chronic bronchopulmonary dysplasia: results of a double-blind crossover sequential trial. Pediatrics 74 (1984) 37-44
23. Bell E.F., Warburton D., Stonestreet B.S., and Oh W. Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. N Engl J Med 302 (1980) 598-604
24. Carswell F., Kerr M.M., and Dunsmore I.R. Sequential trial of effect of phenobarbitone on serum bilirubin of preterm infants. Arch Dis Child 47 (1972) 621-625
25. Cheng K.K., Chang A.M., and Yuen M.P. Prevention of oral mucositis in paediatric patients treated with chemotherapy; a randomised crossover trial comparing two protocols of oral care. Eur J Cancer 40 (2004) 1208-1216
26. Lin Y.J., Yeh T.F., Hsieh W.S., Chi Y.C., Lin H.C., and Lin C.H. Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy. Pediatr Pulmonol 27 (1999) 21-26
27. Valaes T., Drummond G.S., and Kappas A. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin. Pediatrics 101 (1998) E1
28. Bellissant E., Duhamel J.F., Guillot M., Pariente-Khayat A., Olive G., and Pons G. The triangular test to assess the efficacy of metoclopramide in gastroesophageal reflux. Clin Pharmacol Ther 61 (1997) 377-384
29. Samuels M.P., Raine J., Wright T., Alexander J.A., Lockyer K., Spencer S.A., et al. Continuous negative extrathoracic pressure in neonatal respiratory failure. Pediatrics 98 (1996) 1154-1160
30. Gortner L., Pohlandt F., Bartmann P., Bernsau U., Porz F., Hellwege H.H., et al. High-dose versus low-dose bovine surfactant treatment in very premature infants. Acta Paediatr 83 (1994) 135-141
31. Taylor T.E., Molyneux M.E., Wirima J.J., Borgstein A., Goldring J.D., and Hommel M. Intravenous immunoglobulin in the treatment of paediatric cerebral malaria. Clin Exp Immunol 90 (1992) 357-362
32. Gortner L., Bartmann P., Pohlandt F., Bernsau U., Porz F., Hellwege H.H., et al. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial. Pediatr Pulmonol 14 (1992) 4-9
33. Tal A., Levy N., and Bearman J.E. Methylprednisolone therapy for acute asthma in infants and toddlers: a controlled clinical trial. Pediatrics 86 (1990) 350-356
34. Shann F., Barker J., and Poore P. Chloramphenicol alone versus chloramphenicol plus penicillin for severe pneumonia in children. Lancet 2 (1985) 684-686
35. Shann F., Barker J., and Poore P. Chloramphenicol alone versus chloramphenicol plus penicillin for bacterial meningitis in children. Lancet 2 (1985) 681-684
36. Avery G.B., Fletcher A.B., Kaplan M., and Brudno D.S. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 75 (1985) 106-111
37. Barrington K.J., Denson-Lino J., Bloch R., and Finer N.N. Sequential analysis for quality control in the neonatal intensive care unit. J. Pediatr 139 (2001) 778-784
38. Bower M., Bowness P., and Shann F. Penicillin in the treatment of skin sores in children. Med J Aust 140 (1984) 528-530
39. Mammel M.C., Green T.P., Johnson D.E., and Thompson T.R. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1 (1983) 1356-1358
40. Siedentop K.H., and Eggert R.A. Eustachian tube irradiation with strontium 90 in children. Sequential analysis to limit the number of cases. Arch Otolaryngol 98 (1973) 302-305
41. Davis R.L., Kolczak M., Lewis E., Nordin J., Goodman M., Shay D.K., et al. Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology 16 (2005) 336-341
42. Human D.G., Hill I.D., and Fraser C.B. Treatment choice in acute rheumatic carditis. Arch Dis Child 59 (1984) 410-413
43. Jakobsson I., and Lindberg T. Cow's milk proteins cause infantile colic in breast-fed infants: a double-blind crossover study. Pediatrics 71 (1983) 268-271
44. Lampeter E.F., Klinghammer A., Scherbaum W.A., Heinze E., Haastert B., Giani G., et al. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes 47 (1998) 980-984
45. Silverman W.A., Agate F.J., and Fertig J.W. A sequential trial of the nonthermal effect of atmospheric humidity on survival of newborn infants of low birth weight. Pediatrics 31 (1963) 719-724
46. Desfrere L., Zohar S., Morville P., Brunhes A., Chevret S., Pons G., et al. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J Clin Pharm Ther 30 (2005) 121-132
47. Treluyer J.M., Zohar S., Rey E., Hubert P., Iserin F., Jugie M., et al. Minimum effective dose of midazolam for sedation of mechanically ventilated neonates. J Clin Pharm Ther 30 (2005) 479-485
48. van der Tweel I., and van Noord P.A. Early stopping in clinical trials and epidemiologic studies for "futility": conditional power versus sequential analysis. J Clin Epidemiol 56 (2003) 610-617
49. Montori V.M., Devereaux P.J., Adhikari N.K., Burns K.E., Eggert C.H., Briel M., et al. Randomized trials stopped early for benefit: a systematic review. JAMA 294 (2005) 2203-2209
50. Wheatley K., and Clayton D. Be skeptical about unexpected large apparent treatment effects: the case of an MRC AML12 randomization. Control Clin Trials 24 (2003) 66-70
51. Ankum W.M., Reitsma J.B., and Offringa M. IVF with PGS, a promising new treatment with unexpectedly negative health outcomes: the Hippocratic role of Data Monitoring Committees. Hum Reprod 23 (2008) 1-3
52. Bollen C.W., Uiterwaal C.S., van Vught A.J., and van der Tweel I. Sequential meta-analysis of past clinical trials to determine the use of a new trial. Epidemiology 17 (2006) 644-649
53. PEST 4.4 operating manual (2004), The University of Reading, Reading
54. Cytel Software Corporation. EaSt; a software package for the design and interim monitoring of group sequential clinical trials (1992), Cytel Software Corporation, Cambridge, MA